In the last three months, 7 analysts have published ratings on Immunocore Hldgs (NASDAQ:IMCR), offering a diverse range of perspectives from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

Analysts have recently evaluated Immunocore Hldgs and provided 12-month price targets. The average target is $83.29, accompanied by a high estimate of $100.00 and a low estimate of $66.00. Observing a downward trend, the current average is 4.58% lower than the prior average price target of $87.29.

Breaking Down Analyst Ratings: A Detailed Examination

An in-depth analysis of...